Table 6 Retrospective analysis 2: Summary of the revenues generated over the 12-month observation period for dogs included in the analyses of monthly doses
Purchase pattern cohorts | Patients | Revenues generated over the 12-month observation period | |||||
|---|---|---|---|---|---|---|---|
Total FT-HW revenue | Total additional revenue | Total revenue | FT-HW revenue per dog | Additional revenue per dog | Average total revenue per dog | ||
Dual-therapy practices | |||||||
FT only | 44,666 | $4,372,354 | $3,729,598 | $8,101,952 | $97.89 | $83.50 | $181.39 |
HW only | 49,890 | $3,943,702 | $7,576,637 | $11,520,338 | $79.05 | $151.87 | $230.91 |
FT only + HW only | 13,113 | $2,559,390 | $2,567,675 | $5,127,065 | $195.18 | $195.81 | $390.99 |
FT-HW pair | 29,328 | $6,291,415 | $4,963,557 | $11,254,972 | $214.52 | $169.24 | $383.76 |
FT-HW pair + FT only | 11,214 | $3,015,912 | $2,328,455 | $5,344,367 | $268.94 | $207.64 | $476.58 |
FT-HW pair + HW only | 6745 | $1,435,107 | $1,537,452 | $2,972,559 | $212.77 | $227.94 | $440.71 |
FT-HW pair + FT only + HW only | 5898 | $1,788,943 | $1,431,613 | $3,220,556 | $303.31 | $242.73 | $546.04 |
Total | 160,854 | $23,406,823 | $24,134,987 | $47,541,809 | $145.52 | $150.04 | $295.56 |
Purchase pattern cohorts | Patients | Revenues generated over the 12-month observation period | |||||
|---|---|---|---|---|---|---|---|
Total FT-HW revenue | Total additional revenue | Total revenue | FT-HW revenue per dog | Additional revenue per dog | Average total revenue per dog | ||
Combination-therapy practices | |||||||
Combination therapy TOTAL | 85,800 | $16,230,713 | $17,802,845 | $34,033,558 | $189.17 | $207.49 | $396.66 |